|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Minna JD, Roth JA and Gazdar AF: Focus on
lung cancer. Cancer Cell. 1:49–52. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wistuba II: Genetics of preneoplasia:
lessons from lung cancer. Curr Mol Med. 7:3–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller YE: Pathogenesis of lung cancer:
100 year report. Am J Respir Cell Mol Biol. 33:216–223. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eder M and Scherr M: MicroRNA and lung
cancer. N Engl J Med. 352:2446–2448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Landi MT, Zhao Y, Rotunno M, et al:
MicroRNA expression differentiates histology and predicts survival
of lung cancer. Clin Cancer Res. 16:430–441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bishop JA, Benjamin H, Cholakh H, et al:
Accurate classification of non-small cell lung carcinoma using a
novel microRNA-based approach. Clin Cancer Res. 16:610–619. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fassina A, Cappellesso R and Fassan M:
Classification of non-small cell lung carcinoma in transthoracic
needle specimens using microRNA expression profiling. Chest.
140:1305–1311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sassen S, Miska EA and Caldas C: MicroRNA:
implications for cancer. Virchows Archiv. 452:1–10. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K
and Yang GH: MicroRNA-21 (miR-21) represses tumor suppressor PTEN
and promotes growth and invasion in non-small cell lung cancer
(NSCLC). Clin Chim Acta. 411:846–852. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu Z, Liu M, Stribinskis V, et al:
MicroRNA-21 promotes cell transformation by targeting the
programmed cell death 4 gene. Oncogene. 27:4373–4379. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fassan M, Pizzi M, Giacomelli L, et al:
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon
carcinogenesis. Virchows Arch. 458:413–419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang L, Huang Q, Zhang S, et al:
Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small
cell lung cancer and have inverse effects on invasion and migration
of lung cancer cells. BMC cancer. 10:3182010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arora S, Ranade AR, Tran NL, et al:
MicroRNA-328 is associated with (non-small) cell lung cancer
(NSCLC) brain metastasis and mediates NSCLC migration. Int J
Cancer. 129:2621–2631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang X, Ling C, Bai Y and Zhao J:
MicroRNA-206 is associated with invasion and metastasis of lung
cancer. Anat Rec (Hoboken). 294:88–92. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jeong HC, Kim EK, Lee JH, et al: Aberrant
expression of let-7a miRNA in the blood of non-small cell lung
cancer patients. Mol Med Rep. 4:383–387. 2011.PubMed/NCBI
|
|
21
|
Boeri M, Verri C, Conte D, et al: MicroRNA
signatures in tissues and plasma predict development and prognosis
of computed tomography detected lung cancer. Proc Natl Acad Sci
USA. 108:3713–3718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Foss KM, Sima C, Ugolini D, et al:
miR-1254 and miR-574-5p: serum-based microRNA biomarkers for
early-stage non-small cell lung cancer. J Thorac Oncol. 6:482–488.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X, Sempere LF, Ouyang H, et al:
MicroRNA-31 functions as an oncogenic microRNA in mouse and human
lung cancer cells by repressing specific tumor suppressors. J Clin
Invest. 120:1298–1309. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Markou A, Sourvinou I, Vorkas PA, Yousef
GM and Lianidou E: Clinical evaluation of microRNA expression
profiling in non small cell lung cancer. Lung Cancer. 81:388–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Paci M, Rapicetta C and Maramotti S: New
biomarkers for lung cancer. Expert Opin Med Diagn. 4:201–224.
2010.PubMed/NCBI
|
|
26
|
Xu C, Zheng Y, Lian D, et al: Analysis of
microRNA expression profile identifies novel biomarkers for
non-small cell lung cancer. Tumori. 101:104–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Solomides CC, Evans BJ, Navenot JM, et al:
MicroRNA profiling in lung cancer reveals new molecular markers for
diagnosis. Acta Cytol. 56:645–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guan P, Yin Z, Li X, Wu W and Zhou B:
Meta-analysis of human lung cancer microRNA expression profiling
studies comparing cancer tissues with normal tissues. J Exp Clin
Cancer Res. 31:542012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma L, Huang Y, Zhu W, et al: An integrated
analysis of miRNA and mRNA expressions in non-small cell lung
cancers. PloS One. 6:e265022011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abrahamsen HN, Steiniche T, Nexo E, et al:
Towards quantitative mRNA analysis in paraffin-embedded tissues
using real-time reverse transcriptase-polymerase chain reaction: a
methodological study on lymph nodes from melanoma patients. J Mol
Diagn. 5:34–41. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: mir-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Osada H and Takahashi T: let-7 and
miR-17-92: small-sized major players in lung cancer development.
Cancer Sci. 102:9–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
34
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan X, Qin W, Zhang L, et al: A 5-microRNA
signature for lung squamous cell carcinoma diagnosis and hsa-miR-31
for prognosis. Clin Cancer Res. 17:6802–6811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ciafrè SA, Galardi S, Mangiola A, et al:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cahill S, Smyth P, Finn SP, et al: Effect
of ret/PTC 1 rearrangement on transcription and
post-transcriptional regulation in a papillary thyroid carcinoma
model. Mol cancer. 5:702006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao W, Yu Y, Cao H, et al: Deregulated
expression of miR-21, miR-143 and miR-181a in non small cell lung
cancer is related to clinicopathologic characteristics or patient
prognosis. Biomed Pharmacother. 64:399–408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Busacca S, Germano S, De Cecco L, et al:
MicroRNA signature of malignant mesothelioma with potential
diagnostic and prognostic implications. Am J Respir Cell Mol Biol.
42:312–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang JY, Cui SY, Chen YT, et al:
MicroRNA-650 was a prognostic factor in human lung adenocarcinoma
and confers the docetaxel chemoresistance of lung adenocarcinoma
cells via regulating Bcl-2/Bax expression. PloS One. 8:e726152013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiao W, Bao ZX, Zhang CY, et al:
Upregulation of miR-31* is negatively associated with
recurrent/newly formed oral leukoplakia. PloS One. 7:e386482012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Costa A, Afonso J, Osório C, et al:
miR-363-5p regulates endothelial cell properties and their
communication with hematopoietic precursor cells. J Hematol Oncol.
6:872013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu X, Wu X, Wu S, et al: Study on
miR-490-5p and miR-363 as novel biomarkers for the diagnosis of
colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 17:45–50.
2014.(In Chinese). PubMed/NCBI
|
|
44
|
Sun Q, Zhang J, Cao W, et al: Dysregulated
miR-363 affects head and neck cancer invasion and metastasis by
targeting podoplanin. Int J Biochem Cell Biol. 45:513–520. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhi F, Cao X, Xie X, et al: Identification
of circulating microRNAs as potential biomarkers for detecting
acute myeloid leukemia. PloS One. 8:e567182013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kelly AD, Hill KE, Correll M, et al:
Next-generation sequencing and microarray-based interrogation of
microRNAs from formalin-fixed, paraffin-embedded tissue:
preliminary assessment of cross-platform concordance. Genomics.
102:8–14. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Oue N, Anami K, Schetter AJ, et al: High
miR-21 expression from FFPE tissues is associated with poor
survival and response to adjuvant chemotherapy in colon cancer. Int
J Cancer. 134:1926–1934. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Foss RD, Guha-Thakurta N, Conran RM and
Gutman P: Effects of fixative and fixation time on the extraction
and polymerase chain reaction amplification of RNA from
paraffin-embedded tissue. Comparison of two housekeeping gene mRNA
controls. Diagn Mol Pathol. 3:148–155. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Doleshal M, Magotra AA, Choudhury B, et
al: Evaluation and validation of total RNA extraction methods for
microRNA expression analyses in formalin-fixed, paraffin-embedded
tissues. J Mol Diagn. 10:203–211. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jones CI, Zabolotskaya MV, King AJ, et al:
Identification of circulating microRNAs as diagnostic biomarkers
for use in multiple myeloma. Br J Cancer. 107:1987–1996. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Giray BG, Emekdas G, Tezcan S, et al:
Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as
novel biomarkers for HBV-positive hepatocellular carcinoma. Mol
Biol Rep. 41:4513–4519. 2014. View Article : Google Scholar : PubMed/NCBI
|
